The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson's disease
Abstract
Oxidative stress is suggested to play an important role in the pathogenesis of Parkinson's disease (PD). However, no elevation of plasma oxidative stress marker has been reported. We measured percent content of the oxidized form of coenzyme Q10 in total coenzyme Q10 (%CoQ-10) because %CoQ-10 has been shown to be a sensitive marker of oxidative stress. A slight but significant elevation in %CoQ-10 was observed in PD patients when compared with age/gender-matched normal subjects, suggesting elevated systemic oxidative stress in PD patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Significantly decreased levels of CoQ10 have been detected in the cortex of post-mortem brain tissues of Parkinson’s brains. In addition, the level of the oxidized form of ubiquinone has been found to be increased compared to healthy subjects (Sohmiya et al. 2004).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Sohmiya et al. 2004
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Unified Parkinson's Disease Rating Scale
(2012) · Springer eBooks · doi:10.1007/springerreference_184495 · Cited by 3,071
Recent developments in Parkinson's disease
Fahn, S., Elton, R., MARSDEN, C. D., Calne, D. B., & Goldstein, M. (1986) · Raven Press eBooks · Cited by 2,306
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283
Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale
Fahn, S. (1987) · Medical Entomology and Zoology · Cited by 2,163
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. A. D., Dexter, D. T., Jenner, P. G., Clark, J. B., & MARSDEN, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,757
Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease
Dexter, D. T., Carter, C. J., Wells, F. R., Javoy-Agid, F., Agid, Y., Lees, A. J., Jenner, P. G., & MARSDEN, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09133.x · Cited by 1,397
Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149
Abnormalities of the electron transport chain in idiopathic parkinson's disease
Parker, W. D., Boyson, S. J., & Parks, J. K. (1989) · Annals of Neurology · doi:10.1002/ana.410260606 · Cited by 1,061
Flagged first, then by citations
Research works printed but not linked: 1
- Sanchez-Ramos, 1994, A marker of oxyradical-mediated DNA damage (8-hydroxy-2′ deoxyguanosine) is increased in nigro-striatum of Parkinson's disease brain, Neurodegeneration, 3, 197
Cited by
Sorted by citations
Items 101–143 of 143
Petrič, B., Redenšek, S., Dolžan, V., Kramberger, M. G., Trošt, M., Maraković, N., Goličnik, M., & Bavec, A. (2023) · Antioxidants · doi:10.3390/antiox12020399 · Cited by 10
Tasaki, E., Yamamoto, Y., & Iuchi, Y. (2023) · Insect Science · doi:10.1111/1744-7917.13217 · Cited by 10
Self-citationHjazi, A. M., Ahsan, M., Alghamdi, M., Kareem, A. K., Al‐Saidi, D. N., Qasim, M. T., Romero‐Parra, R. M., Zabibah, R. S., Ramírez‐Coronel, A. A., Mustafa, Y. F., et al. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154737 · Cited by 10
Abdel‐Salam, O. M. E., Khadrawy, Y. A., Youness, E. R., Mohammed, N. A., Abdel-Rahman, R. F., Hussein, J., & Shafee, N. (2013) · Comparative Clinical Pathology · doi:10.1007/s00580-013-1807-4 · Cited by 10
Effect of dopaminergic neurotoxin MPTP/MPP+ on coenzyme Q content
Dhanasekaran, M., Karuppagounder, S. S., Uthayathas, S., Wold, L. E., Parameshwaran, K., Babu, R. J., Suppiramaniam, V. D., & Brown‐Borg, H. M. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.04.016 · Cited by 10
Lipid profile in Parkinson's disease: The potential role of brain-derived neurotrophic factor
Alomari, M. A., Khalil, H. W., Khabour, O. F., & Alzoubi, K. H. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121144 · Cited by 10
Nagase, M., Yamamoto, Y., Mitsui, J., & Tsuji, S. (2018) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.17-131 · Cited by 9
Self-citationLiu, Y., Zhuang, Z., Liao, Z., Yao, R., Chen, M., Wei, H., Zhao, W., & Niu, J. (2023) · Antioxidants · doi:10.3390/antiox12122042 · Cited by 8
Unveiling Parkinson’s disease through biomarker research: current insights and future prospects
Çelik, N. D., Özben, S., & Özben, T. (2024) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2024.2331471 · Cited by 8
Park, K., Hwang, C. J., Yun, H., Yeo, I. J., Choi, D., Park, P., Kim, H., Lee, J. T., Jung, Y. S., Han, S., et al. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01590-1 · Cited by 8
Autonomic dysfunction in early and advanced Parkinson's disease
Pursiainen, V. (2007) · Cited by 8
Tang, P., & Miles, M. V. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-504-6_10 · Cited by 7
TANIGUCHI, M., Sato, A., Honda, K., Ohgo, S., & Yoshimura, K. (1986) · PubMed · Cited by 7
Takasu, A., Shibata, M., Uchino, S., Nishi, K., Yamamoto, Y., & Sakamoto, T. (2010) · Resuscitation · doi:10.1016/j.resuscitation.2010.10.007 · Cited by 6
Self-citationPrevention of Parkinson’s Disease: From Risk Factors to Early Interventions
Ng, M. G., Chan, B. J. L., Koh, R. Y., Ng, K. Y., & Chye, S. M. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230616092054 · Cited by 6
Oxidized proportion of muscle coenzyme Q10 increases with age in healthy children
Niklowitz, P., Scherer, J., Döring, F., Paulussen, M., & Menke, T. (2015) · Pediatric Research · doi:10.1038/pr.2015.124 · Cited by 6
Potential Protein Blood-based Biomarkers in Different Types of Dementia: A Therapeutic Overview
Manzine, P. R., Vatanabe, I. P., Grigoli, M. M., Pedroso, R. V., Monteiro, M. P. A. O., de Oliveira, D. D. S. M. S., Nascimento, C. M. C., Peron, R., Orlandi, F. D. S., & Cominetti, M. R. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220408124809 · Cited by 4
Fontaine, F., Legallois, D., Créveuil, C., Chtourou, M., Coulbault, L., Milliez, P., Hodžić, A., Saloux, É., Beygui, F., & Allouche, S. (2021) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/00045632211001100 · Cited by 4
Ershadi, A. S. B., & Hosseini, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817933-8.00036-0 · Cited by 4
Smoking habits and coenzyme Q10 status in healthy European adults
Niklowitz, P., Fischer, A., Onur, S., Paulussen, M., Menke, T., & Döring, F. (2016) · Archives of Medical Science · doi:10.5114/aoms.2016.60953 · Cited by 4
Biochemical Markers in Parkinson's Disease
Čeprnja, M., & Vuletić, V. (2020) · Neurology - Research & Surgery · doi:10.33425/2641-4333.1032 · Cited by 3
El-sayed, A. (2019) · Annals of Agricultural Science Moshtohor · doi:10.21608/assjm.2019.42155 · Cited by 3
El-Reffaei, W., El-Sebeay, A., El-Ghandour, H., Ragheb, E. M., & Badr, S. E. A. (2016) · Journal of Food and Dairy Sciences · doi:10.21608/jfds.2016.42815 · Cited by 3
Coenzyme Q10, Free Radicals, and Heart Disease
Yamamoto, Y. (2005) · Oxidative stress and disease · doi:10.1201/9781420027174.ch4 · Cited by 3
Self-citationGhorpade, K. B., Agrawal, S., & Havelikar, U. A. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102656 · Cited by 3
RetractedEl-Bakry, R., EL-Fetouh, K., Sakr, M., & Ali, A. A. (2021) · Azhar International Journal of Pharmaceutical and Medical Sciences/Azhar International Journal of Pharmaceutical and Medical Sciences · doi:10.21608/aijpms.2021.77442.1074 · Cited by 2
Coenzyme Q and Age-Related Neurodegenerative Disorders: Parkinson and Alzheimer Diseases
Alcain, F. J., Domínguez, J., Durán‐Prado, M., & Vaamonde, J. (2020) · Springer eBooks · doi:10.1007/978-3-030-45642-9_12 · Cited by 2
TAKAHASHI, T., & Okamoto, T. (2026) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.72.120 · Cited by 1
Kawai, K., IINO, T., Thanatuksorn, P., Yamamoto, Y., & Kajiwara, K. (2010) · Journal of Food Biochemistry · doi:10.1111/j.1745-4514.2010.00351.x · Cited by 1
Self-citationIs hyperlipidemia a risk factor of Parkinson’s disease?
Gutorova, D. A., Vasenina, E. D., Васенина, Е. Е., & Levin, O. S. (2015) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20151156261-64 · Cited by 1
Role of dietary antioxidants and redox status in Parkinson's disease
Amani, R., & Mehrabani, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89834-8.00048-9 · Cited by 1
Plasma Marker of Oxidative Stress in Circulation and in Tissue
Yamamoto, Y. (2010) · Frontiers of gastrointestinal research · doi:10.1159/000319942 · Cited by 1
Self-citationSawashita, J., Xu, Z., & Higuchi, K. (2020) · Springer eBooks · doi:10.1007/978-3-030-45642-9_9 · Cited by 1
Vascular Risk Factors and the Risk of Parkinson's Disease: Some New Findings
Hu, G. (2009) · North American Journal of Medicine and Science · doi:10.7156/v2i3p102
Tropea, T. F., & Henchcliffe, C. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781107284210.024
Clinical Trials in Parkinson's Diease: Lessons, Controversies and Challenges
(2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781107284210.022
Experimental Models and New, Emerging Therapies for Parkinson Disease
Fahn, S., Jankovic, J. J., Hallett, M., & Jenner, P. G. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-07941-2.50012-7
Parkinson's Disease and Serum Cholesterol Levels: A Case Control Study
Köksal, A., Sözmen, V., Dirican, A. C., Altunkaynak, Y., Arslan, E., & Baybaş, S. (2013) · Journal of Neurological Sciences-turkish
Biomarker in Parkinson’s Disease: Clinical and Biochemical Biomarker
Lee, J.-Y., Ma, H., & Kim, Y. E. (2021) · Journal of the Korean Neurological Association · doi:10.17340/jkna.2021.4.4
Coenzyme Q10 and its Therapeutic Effect on Tinnitus
Swain, S. K. (2025) · SBV Journal of Basic Clinical and Applied Health Science · doi:10.4103/sbvj.sbvj_65_25
Stürmer, P., Weber, K. S., Strathmann, E. A., Övermöhle, C., Voran, J. C., Döring, F., Laudes, M., & Lieb, W. (2026) · Antioxidants · doi:10.3390/antiox15030343
Resolving the subcellular redox landscape of Coenzyme Q
Kim, T. H., Nguyen, C. T. N., Jang, D., Lee, S. B., Cha, Y. J., Kim, S. M., Lim, Y. J., Choi, T. H., Kim, T., Lee, J.-Y., et al. (2026) · Cell chemical biology · doi:10.1016/j.chembiol.2026.07.001
Metadata
- Authors
- Sohmiya, M., Tanaka, M., Wei Tak, N., Yanagisawa, M., Tanino, Y., Suzuki, Y., Okamoto, K., & Yamamoto, Y.
- Affiliations
- Gunma University (JP)
- The University of Tokyo (JP)
- Tokyo University of Technology (JP)
- Corresponding author
- Sohmiya, Makoto
- ORCID
- Okamoto, Koichi
- Venue
- Journal of the Neurological Sciences
- Publisher
- Elsevier BV
- Published
- 2004-08
- Volume
- 223
- Issue
- 2
- Pages
- 161-166
- ISSN
- 0022-510X (ISSN-L)
- OpenAlex
- W2117733672
- Cited by
- 143
- References
- 52
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 2 · 2023: 10 · 2022: 5 · 2021: 7 · 2020: 14 · 2019: 4 · 2018: 5 · 2017: 3 · 2016: 7 · 2015: 7 · 2014: 4 · 2013: 8 · 2012: 6
- FWCI
- 2.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Journal of the Neurological Sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- Parkinson's disease, oxidative stress, coenzyme Q10, plasma biomarkers, redox state, neurodegeneration
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alzheimer Disease, Chromatography, High Pressure Liquid, Coenzymes, Electrochemistry, Female, Humans, Male, Middle Aged, Oxidation-Reduction, Parkinson Disease, Plasma, Ubiquinone, Case-Control Studies, Oxidative Stress, Statistics, Nonparametric
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review